Global Oral Contrast Agent Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Oral Contrast Agent market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Oral Contrast Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Oral Contrast Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Oral Contrast Agent market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Oral Contrast Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Oral Contrast Agent market include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Contrast Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Oral Contrast Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Contrast Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Contrast Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral Contrast Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral Contrast Agent sales, projected growth trends, production technology, application and end-user industry.
Oral Contrast Agent Segment by Company
Daiichi Sankyo (Japan)
Bayer HealthCare (Germany)
Unijules Life Sciences (India)
Taejoon Pharm (South Korea)
Spago Nanomedicine (Sweden)
Magnus Health (India)
Lantheus (US)
Jodas (India)
J.B. Chemicals and Pharmaceuticals (India)
Guerbet (France)
GE Healthcare (US)
Bracco Imaging (Italy)
Oral Contrast Agent Segment by Type
Microbubble Contrast Media
Gadolinium-based Contrast Media
Iodinated Contrast Media
Barium-based Contrast Media
Oral Contrast Agent Segment by Application
Cardiovascular Disorders
Gastrointestinal Disorders
Nephrological Disorders
Neurological Disorders
Musculoskeletal Disorders
Cancer
Oral Contrast Agent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Oral Contrast Agent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Oral Contrast Agent market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Oral Contrast Agent significant trends, drivers, influence factors in global and regions.
6. To analyze Oral Contrast Agent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Contrast Agent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Contrast Agent industry.
Chapter 3: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Oral Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Oral Contrast Agent in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Oral Contrast Agent market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Oral Contrast Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Oral Contrast Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Oral Contrast Agent market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Oral Contrast Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Oral Contrast Agent market include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Contrast Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Oral Contrast Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Contrast Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Contrast Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral Contrast Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral Contrast Agent sales, projected growth trends, production technology, application and end-user industry.
Oral Contrast Agent Segment by Company
Daiichi Sankyo (Japan)
Bayer HealthCare (Germany)
Unijules Life Sciences (India)
Taejoon Pharm (South Korea)
Spago Nanomedicine (Sweden)
Magnus Health (India)
Lantheus (US)
Jodas (India)
J.B. Chemicals and Pharmaceuticals (India)
Guerbet (France)
GE Healthcare (US)
Bracco Imaging (Italy)
Oral Contrast Agent Segment by Type
Microbubble Contrast Media
Gadolinium-based Contrast Media
Iodinated Contrast Media
Barium-based Contrast Media
Oral Contrast Agent Segment by Application
Cardiovascular Disorders
Gastrointestinal Disorders
Nephrological Disorders
Neurological Disorders
Musculoskeletal Disorders
Cancer
Oral Contrast Agent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Oral Contrast Agent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Oral Contrast Agent market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Oral Contrast Agent significant trends, drivers, influence factors in global and regions.
6. To analyze Oral Contrast Agent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Contrast Agent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Contrast Agent industry.
Chapter 3: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Oral Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Oral Contrast Agent in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
191 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oral Contrast Agent Sales Value (2020-2031)
- 1.2.2 Global Oral Contrast Agent Sales Volume (2020-2031)
- 1.2.3 Global Oral Contrast Agent Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Oral Contrast Agent Market Dynamics
- 2.1 Oral Contrast Agent Industry Trends
- 2.2 Oral Contrast Agent Industry Drivers
- 2.3 Oral Contrast Agent Industry Opportunities and Challenges
- 2.4 Oral Contrast Agent Industry Restraints
- 3 Oral Contrast Agent Market by Company
- 3.1 Global Oral Contrast Agent Company Revenue Ranking in 2024
- 3.2 Global Oral Contrast Agent Revenue by Company (2020-2025)
- 3.3 Global Oral Contrast Agent Sales Volume by Company (2020-2025)
- 3.4 Global Oral Contrast Agent Average Price by Company (2020-2025)
- 3.5 Global Oral Contrast Agent Company Ranking (2023-2025)
- 3.6 Global Oral Contrast Agent Company Manufacturing Base and Headquarters
- 3.7 Global Oral Contrast Agent Company Product Type and Application
- 3.8 Global Oral Contrast Agent Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Oral Contrast Agent Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Oral Contrast Agent Market by Type
- 4.1 Oral Contrast Agent Type Introduction
- 4.1.1 Microbubble Contrast Media
- 4.1.2 Gadolinium-based Contrast Media
- 4.1.3 Iodinated Contrast Media
- 4.1.4 Barium-based Contrast Media
- 4.2 Global Oral Contrast Agent Sales Volume by Type
- 4.2.1 Global Oral Contrast Agent Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Oral Contrast Agent Sales Volume by Type (2020-2031)
- 4.2.3 Global Oral Contrast Agent Sales Volume Share by Type (2020-2031)
- 4.3 Global Oral Contrast Agent Sales Value by Type
- 4.3.1 Global Oral Contrast Agent Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Oral Contrast Agent Sales Value by Type (2020-2031)
- 4.3.3 Global Oral Contrast Agent Sales Value Share by Type (2020-2031)
- 5 Oral Contrast Agent Market by Application
- 5.1 Oral Contrast Agent Application Introduction
- 5.1.1 Cardiovascular Disorders
- 5.1.2 Gastrointestinal Disorders
- 5.1.3 Nephrological Disorders
- 5.1.4 Neurological Disorders
- 5.1.5 Musculoskeletal Disorders
- 5.1.6 Cancer
- 5.2 Global Oral Contrast Agent Sales Volume by Application
- 5.2.1 Global Oral Contrast Agent Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Oral Contrast Agent Sales Volume by Application (2020-2031)
- 5.2.3 Global Oral Contrast Agent Sales Volume Share by Application (2020-2031)
- 5.3 Global Oral Contrast Agent Sales Value by Application
- 5.3.1 Global Oral Contrast Agent Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Oral Contrast Agent Sales Value by Application (2020-2031)
- 5.3.3 Global Oral Contrast Agent Sales Value Share by Application (2020-2031)
- 6 Oral Contrast Agent Regional Sales and Value Analysis
- 6.1 Global Oral Contrast Agent Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Oral Contrast Agent Sales by Region (2020-2031)
- 6.2.1 Global Oral Contrast Agent Sales by Region: 2020-2025
- 6.2.2 Global Oral Contrast Agent Sales by Region (2026-2031)
- 6.3 Global Oral Contrast Agent Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Oral Contrast Agent Sales Value by Region (2020-2031)
- 6.4.1 Global Oral Contrast Agent Sales Value by Region: 2020-2025
- 6.4.2 Global Oral Contrast Agent Sales Value by Region (2026-2031)
- 6.5 Global Oral Contrast Agent Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Oral Contrast Agent Sales Value (2020-2031)
- 6.6.2 North America Oral Contrast Agent Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Oral Contrast Agent Sales Value (2020-2031)
- 6.7.2 Europe Oral Contrast Agent Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Oral Contrast Agent Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Oral Contrast Agent Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Oral Contrast Agent Sales Value (2020-2031)
- 6.9.2 South America Oral Contrast Agent Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Oral Contrast Agent Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Oral Contrast Agent Sales Value Share by Country, 2024 VS 2031
- 7 Oral Contrast Agent Country-level Sales and Value Analysis
- 7.1 Global Oral Contrast Agent Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Oral Contrast Agent Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Oral Contrast Agent Sales by Country (2020-2031)
- 7.3.1 Global Oral Contrast Agent Sales by Country (2020-2025)
- 7.3.2 Global Oral Contrast Agent Sales by Country (2026-2031)
- 7.4 Global Oral Contrast Agent Sales Value by Country (2020-2031)
- 7.4.1 Global Oral Contrast Agent Sales Value by Country (2020-2025)
- 7.4.2 Global Oral Contrast Agent Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.9.2 France Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.16.2 China Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.19.2 India Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Oral Contrast Agent Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Oral Contrast Agent Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Oral Contrast Agent Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Daiichi Sankyo (Japan)
- 8.1.1 Daiichi Sankyo (Japan) Comapny Information
- 8.1.2 Daiichi Sankyo (Japan) Business Overview
- 8.1.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
- 8.1.5 Daiichi Sankyo (Japan) Recent Developments
- 8.2 Bayer HealthCare (Germany)
- 8.2.1 Bayer HealthCare (Germany) Comapny Information
- 8.2.2 Bayer HealthCare (Germany) Business Overview
- 8.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
- 8.2.5 Bayer HealthCare (Germany) Recent Developments
- 8.3 Unijules Life Sciences (India)
- 8.3.1 Unijules Life Sciences (India) Comapny Information
- 8.3.2 Unijules Life Sciences (India) Business Overview
- 8.3.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
- 8.3.5 Unijules Life Sciences (India) Recent Developments
- 8.4 Taejoon Pharm (South Korea)
- 8.4.1 Taejoon Pharm (South Korea) Comapny Information
- 8.4.2 Taejoon Pharm (South Korea) Business Overview
- 8.4.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
- 8.4.5 Taejoon Pharm (South Korea) Recent Developments
- 8.5 Spago Nanomedicine (Sweden)
- 8.5.1 Spago Nanomedicine (Sweden) Comapny Information
- 8.5.2 Spago Nanomedicine (Sweden) Business Overview
- 8.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
- 8.5.5 Spago Nanomedicine (Sweden) Recent Developments
- 8.6 Magnus Health (India)
- 8.6.1 Magnus Health (India) Comapny Information
- 8.6.2 Magnus Health (India) Business Overview
- 8.6.3 Magnus Health (India) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
- 8.6.5 Magnus Health (India) Recent Developments
- 8.7 Lantheus (US)
- 8.7.1 Lantheus (US) Comapny Information
- 8.7.2 Lantheus (US) Business Overview
- 8.7.3 Lantheus (US) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Lantheus (US) Oral Contrast Agent Product Portfolio
- 8.7.5 Lantheus (US) Recent Developments
- 8.8 Jodas (India)
- 8.8.1 Jodas (India) Comapny Information
- 8.8.2 Jodas (India) Business Overview
- 8.8.3 Jodas (India) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Jodas (India) Oral Contrast Agent Product Portfolio
- 8.8.5 Jodas (India) Recent Developments
- 8.9 J.B. Chemicals and Pharmaceuticals (India)
- 8.9.1 J.B. Chemicals and Pharmaceuticals (India) Comapny Information
- 8.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
- 8.9.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.9.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
- 8.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
- 8.10 Guerbet (France)
- 8.10.1 Guerbet (France) Comapny Information
- 8.10.2 Guerbet (France) Business Overview
- 8.10.3 Guerbet (France) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Guerbet (France) Oral Contrast Agent Product Portfolio
- 8.10.5 Guerbet (France) Recent Developments
- 8.11 GE Healthcare (US)
- 8.11.1 GE Healthcare (US) Comapny Information
- 8.11.2 GE Healthcare (US) Business Overview
- 8.11.3 GE Healthcare (US) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.11.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
- 8.11.5 GE Healthcare (US) Recent Developments
- 8.12 Bracco Imaging (Italy)
- 8.12.1 Bracco Imaging (Italy) Comapny Information
- 8.12.2 Bracco Imaging (Italy) Business Overview
- 8.12.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Value and Gross Margin (2020-2025)
- 8.12.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
- 8.12.5 Bracco Imaging (Italy) Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Oral Contrast Agent Value Chain Analysis
- 9.1.1 Oral Contrast Agent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Oral Contrast Agent Sales Mode & Process
- 9.2 Oral Contrast Agent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oral Contrast Agent Distributors
- 9.2.3 Oral Contrast Agent Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


